| |
Welcome |
 |
Immunomic Therapeutics' website is your resource for news & updates about the Company as well a wealth of technical and informational content.
For general information about ITI, its management team and our vision, we invite you to explore the About Us section. If you are interested in learning a little basic immunology and how vaccines can be used to treat allergies, visit our Immunology 101 section. We are also planning on adding a multi-media section to further your understanding of LAMP-vax Technology and our developing vaccine product line.
|
|
About us |
|
Immunomic Therapeutics, Inc. (ITI) is a development stage biotechnology company with exceptional science for application to vaccines and vaccine immunotherapies.
The promise of our LAMP-vax Technology is to increase the effectiveness of the immune response to DNA vaccines while simplifying overall vaccine design and delivery. The LAMP-vax Technology is ideally suited for application to allergy immunotherapy and the company is planning to initiate a clinical study in 2009. There is both industry and clinical validation for this breakthrough science.
|
|
Latest news |
|
February 25th, 2009
The 2008 Annual Report was released to Shareholders today. If you are interested in receiving a copy, please contact the ITI using the mail link on this page..
January 2nd, 2009
ITI Set to Meet with FDA in March 2009 on its Allergy Vaccine Proposed Clincial Trial. Press release pending.
November 7th, 2008
ITI Announces Addition of Dr. Larry Weiner to the Scientific Advisory Board. more information is available about this exciting addition to the Company; Dr. Weiner is a highly experience allergist and will be providing technical direction on the forthcoming clinical studies planned by the Company.
|
|
